Back to Search
Start Over
Lapatinib versus placebo added to paclitaxel in first-line human epidermal growth factor receptor 2-positive metastatic breast cancer: ethical lessons not learned from Africa
- Source :
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(33)
- Publication Year :
- 2013
- Subjects :
- Oncology
Cancer Research
medicine.medical_specialty
Paclitaxel
Receptor, ErbB-2
First line
Breast Neoplasms
Placebo
Lapatinib
chemistry.chemical_compound
Text mining
Internal medicine
Antineoplastic Combined Chemotherapy Protocols
medicine
Biomarkers, Tumor
Humans
Human Epidermal Growth Factor Receptor 2
Protein Kinase Inhibitors
business.industry
Protein-Tyrosine Kinases
medicine.disease
Metastatic breast cancer
chemistry
Quinazolines
Female
business
medicine.drug
Subjects
Details
- ISSN :
- 15277755
- Volume :
- 31
- Issue :
- 33
- Database :
- OpenAIRE
- Journal :
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- Accession number :
- edsair.doi.dedup.....4eb5ff86cea1d868081bc161394a7d66